These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37239273)

  • 1. Neuroimaging Correlates of Treatment Response to Transcranial Magnetic Stimulation in Bipolar Depression: A Systematic Review.
    Shamabadi A; Karimi H; Cattarinussi G; Moghaddam HS; Akhondzadeh S; Sambataro F; Schiena G; Delvecchio G
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.
    Val-Laillet D; Aarts E; Weber B; Ferrari M; Quaresima V; Stoeckel LE; Alonso-Alonso M; Audette M; Malbert CH; Stice E
    Neuroimage Clin; 2015; 8():1-31. PubMed ID: 26110109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.
    Richieri R; Jouvenoz D; Verger A; Fiat P; Boyer L; Lançon C; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1051-1055. PubMed ID: 28154905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled Trial.
    Pszczolkowski S; Cottam WJ; Briley PM; Iwabuchi SJ; Kaylor-Hughes C; Shalabi A; Babourina-Brooks B; Berrington A; Barber S; Suazo Di Paola A; Blamire A; McAllister-Williams RH; Parikh J; Abdelghani M; Matthäus L; Hauffe R; Liddle P; Auer DP; Morriss R
    JMIR Res Protoc; 2022 Jan; 11(1):e31925. PubMed ID: 35049517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression.
    Richieri R; Boyer L; Farisse J; Colavolpe C; Mundler O; Lancon C; Guedj E
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1715-22. PubMed ID: 21647787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Downar J; Geraci J; Salomons TV; Dunlop K; Wheeler S; McAndrews MP; Bakker N; Blumberger DM; Daskalakis ZJ; Kennedy SH; Flint AJ; Giacobbe P
    Biol Psychiatry; 2014 Aug; 76(3):176-85. PubMed ID: 24388670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review.
    Gonsalves MA; White TL; Barredo J; Fukuda AM; Joyce HE; Harris AD; Carpenter LL
    Neuroimage Clin; 2022; 35():103049. PubMed ID: 35738081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight Into the Effects of Clinical Repetitive Transcranial Magnetic Stimulation on the Brain From Positron Emission Tomography and Magnetic Resonance Imaging Studies: A Narrative Review.
    Aceves-Serrano L; Neva JL; Doudet DJ
    Front Neurosci; 2022; 16():787403. PubMed ID: 35264923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation in schizophrenia: the contribution of neuroimaging.
    Du ZD; Wang R; Prakash R; Chaudhury S; Dayananda G
    Curr Top Med Chem; 2012; 12(21):2452-7. PubMed ID: 23409741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-week rTMS-induced neuroimaging changes measured with fMRI in depression.
    Zheng A; Yu R; Du W; Liu H; Zhang Z; Xu Z; Xiang Y; Du L
    J Affect Disord; 2020 Jun; 270():15-21. PubMed ID: 32275215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression.
    Kito S; Hasegawa T; Koga Y
    Brain Stimul; 2012 Oct; 5(4):547-53. PubMed ID: 22019081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS.
    Richieri R; Boyer L; Padovani R; Adida M; Colavolpe C; Mundler O; Lançon C; Guedj E
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):364-70. PubMed ID: 22850205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression.
    Harika-Germaneau G; Wassouf I; Le Tutour T; Guillevin R; Doolub D; Rostami R; Delbreil A; Langbour N; Jaafari N
    Front Psychiatry; 2022; 13():894473. PubMed ID: 35669263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the after-effects of theta burst stimulation on the human auditory cortex with functional imaging.
    Andoh J; Zatorre RJ
    J Vis Exp; 2012 Sep; (67):e3985. PubMed ID: 23007549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study.
    Richieri R; Verger A; Boyer L; Boucekine M; David A; Lançon C; Cermolacce M; Guedj E
    Brain Stimul; 2018; 11(5):1093-1097. PubMed ID: 29802071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between bipolar and unipolar depression in functional and structural MRI studies.
    Han KM; De Berardis D; Fornaro M; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():20-27. PubMed ID: 29601896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review and Meta-Analysis of Randomized Sham-Controlled Trials of Repetitive Transcranial Magnetic Stimulation for Bipolar Disorder.
    Tee MMK; Au CH
    Psychiatr Q; 2020 Dec; 91(4):1225-1247. PubMed ID: 32860557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
    Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
    BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.